Financhill
Back

Emergent BioSolutions Quote, Financials, Valuation and Earnings

Stock Market Legend Shares Biggest Prediction Ever:

Click Here to See
Buy
55

EBS
Emergent BioSolutions

Last Price:
3.29
Seasonality Move:
4.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Master the Market: The Formula for a 96.3% Win Rate Revealed!

Act now!

Emergent BioSolutions Price Quote

$3.29
-0.01 (70.47%)
(Updated: May 3, 2024 at 4:36 AM ET)

Emergent BioSolutions Key Stats

Buy
55
Emergent BioSolutions (EBS) is a Buy

Day range:
$2.82 - $4.76
52-week range:
$1.42 - $10.88
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.17
P/B ratio:
0.27%

Volume:
151M
Avg. volume:
6.1M
1-year change:
-60.1%
Market cap:
$172.3M
Revenue:
$1B
EPS:
$-14.76

How Much Does Emergent BioSolutions Make?

Is Emergent BioSolutions Growing As A Company?

  • What Is Emergent BioSolutions's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.16%
  • What Is Emergent BioSolutions's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Emergent BioSolutions Stock Price Performance

What Is Emergent BioSolutions 52-Week High & Low?

Emergent BioSolutions Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Emergent BioSolutions?

Is Emergent BioSolutions Cash Flow Positive?

  • What Is EBS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$206.3M
  • What Is Emergent BioSolutions’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$535.7M
  • What Is Emergent BioSolutions’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $212.3M

Emergent BioSolutions Return On Invested Capital

  • Is Management Doing A Good Job?
    EBS return on invested capital is -36.68%
  • What Is Emergent BioSolutions Return On Assets?
    ROA measures how assets are converting to revenues and is -31.52%
  • What Is EBS Return On Equity?
    ROE is a measure of profitability and is -77.37%

Emergent BioSolutions Earnings Date & Stock Price

Emergent BioSolutions Competitors

Emergent BioSolutions Dividend Yield

Data Unavailable

Emergent BioSolutions Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 168.69%
Revenue: -16.47% 36.39%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 5.00
Upside from Last Price: 51.52%

Major Shareholders

  • How many EBS shares are owned by institutional investors?
    53.6M EBS shares are owned by institutional investors
  • How many EBS shares are owned by insiders?
    3.7M EBS shares are owned by insiders